Financial Management Professionals, Inc. Adverum Biotechnologies, Inc. Transaction History

Financial Management Professionals, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 24, 2020	SELL	$7.98 - $16.32 $798 - $1,632	-100 Closed	0 $0
Q4 2019 Jan 21, 2020	BUY	$5.12 - $12.22 $512 - $1,222	100 New	100 $1,000
Q3 2019 Oct 11, 2019	SELL	$5.24 - $15.89 $1,572 - $4,767	-300 Closed	0 $0
Q2 2019 Jul 29, 2019	BUY	$5.1 - $11.89 $1,530 - $3,567	300 New	300 $4,000

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $464M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Financial Management Professionals, Inc., based on Form 13F filings with the SEC.

Stay updated on Financial Management Professionals, Inc. with notifications on news.